US › Healthcare

Schrodinger Inc (SDGR)

US · Healthcare · Health Information Services

$15.65+2.42%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$58.6M
Revenue YoY
-1.6%
Net profit
$-60.0M
Profit YoY
-0.4%
EPS
$-0.62
EPS estimate
$-0.57
Net margin
-102.5%

EPS came in at -0.62 against a street estimate of -0.57 — a miss of 8.8%.

Key statistics

Market cap
$1.13B
Forward P/E
0.0
P/B
3.61
Book value
$4.21
EPS (TTM)
$-1.40
52-week high
$23.02
52-week low
$10.95
50-day MA
$15.26
200-day MA
$15.24
Beta
1.62

Analyst view

Analysts rate Schrodinger Inc a strong buy (6 buy, 2 hold, 0 sell out of 8) with an average price target of $20.57.

Shareholding

Insiders
3.01%
Institutions
99.44%

Largest institutional holders

FundStake
BlackRock Inc12.95%
Gates Bill & Melinda Foundation9.34%
Rubric Capital Management LP8.03%
Vanguard Portfolio Management, LLC5.17%
Amova Asset Management Americas, Inc4.27%
Sumitomo Mitsui Trust Group Inc4.27%
Massachusetts Financial Services Company3.59%
UBS Asset Mgmt Americas Inc3.56%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Schrodinger Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.